Vestal Point Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.1M Hold
1,500,000
2.27% 16
2025
Q1
$50.3M Buy
+1,500,000
New +$50.3M 3.59% 8
2024
Q4
Sell
-205,000
Closed -$10.5M 82
2024
Q3
$10.5M Buy
+205,000
New +$10.5M 0.79% 30
2024
Q1
Sell
-450,000
Closed -$16M 63
2023
Q4
$16M Buy
+450,000
New +$16M 1.7% 20